Revascularization and survival in multivessel coronary artery disease in ischemia

Affiliations

¹ Division of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University, Stanford, Calif.
² Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, Calif.
³ New York University, Grossman School of Medicine, New York, NY.

David J Maron et al. JTCVS Open. 2022.

. 2022 Apr 14:10:243.

doi: 10.1016/j.xjon.2022.03.006. eCollection 2022 Jun.

¹ Division of Cardiovascular Medicine and the Cardiovascular Institute, Stanford University, Stanford, Calif.
² Department of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, Calif.
³ New York University, Grossman School of Medicine, New York, NY.

No abstract available

Figures

1. Sabik J.F., III, Bakaeen F.G., Ruel M., Moon M.R., Malaisrie S.C., Calhoon J.H., et al. The American Association for Thoracic Surgery and Society of Thoracic Surgeons reasoning for not endorsing the 2021 ACC/AHA/SCAI coronary revascularization guidelines. J Thorac Cardiovasc Surg. 2022;163:1362–1365. - PubMed
1. Writing Committee Members. Lawton J.S., Tamis-Holland J.E., Bangalore S., Bates E.R., Beckie T.M., Bischoff J.M., et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:197–215. - PubMed
1. Maron D.J., Hochman J.S., Reynolds H.R., Bangalore S., O'Brien S.M., Boden W.E., et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–1407. - PMC - PubMed
1. Reynolds H.R., Shaw L.J., Min J.K., Page C.B., Berman D.S., Chaitman B.R., et al. Outcomes in the ISCHEMIA trial based on coronary artery disease and ischemia severity. Circulation. 2021;144:1024–1038. - PMC - PubMed